Improving outcomes in type 1 diabetes
As a leading researcher in the field of automated insulin delivery systems, Dr. Kudva is bringing new hope to people with diabetes.
Overview
As a dedicated physician-scientist, Yogish C. Kudva, M.B.B.S., is working to develop an effective artificial pancreas and automated insulin delivery (AID) system to improve outcomes for people with type 1 and type 2 diabetes.
Dr. Kudva's research also contributes to the creation of new and better cell replacement therapies for people with type 1 diabetes along with automation work on insulin delivery systems in people who are pregnant and have preexisting type 1 diabetes.
The goal of our research in the Artificial Pancreas Laboratory is to accelerate approval of the artificial endocrine pancreas to treat type 1 and type 2 diabetes. By implementing AID studies, we're investigating, defining, understanding and developing physiological models of integrative physiology related to the insulin-glucose system.
We're seeking a better understanding of the insulin-glucose system as it relates to meals, physical activity, menstrual cycles, sleep cycles and other variables. This knowledge helps inform, develop, refine and validate personalized, state-of-the-art AID systems to improve the quality of life for people with type 1 diabetes. We're committed to improving existing methods and developing innovative techniques to measure physiological parameters related to these variables.
Funding
Our lab's work is supported by a variety of extramural funding. This includes grants from the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Helmsley Charitable Trust.
Dr. Kudva also was awarded funding to be part of a consortium to merge physiology, behavior and engineering approaches to optimize automated insulin delivery systems and provide tight glucose control that can be applied in outpatient settings.
About Dr. Kudva
Dr. Kudva is an endocrinologist at Mayo Clinic in Rochester, Minnesota. He also is a professor of medicine at Mayo Clinic College of Medicine and Science. He has the distinction of being the Dr. Richard F. Emslander Professor II. Dr. Kudva also is working to develop stem cell therapy and to improve outcomes for people undergoing kidney transplant and pancreas transplant. His work also includes new diabetes technology testings, including AID systems and continuous glucose monitors, in people with type 2 diabetes.